Language:English
Language:

Xcessbio

Place your promotion here

You have no items in your shopping cart.

KDM5-C70, JARID1 Histone Demethylases Inhibitor

KDM5-C70, JARID1 Histone Demethylases Inhibitor

$139.00
An ethyl ester derivative of KDM5-C49, which is a potent and selective inhibitor of Jumonji AT-Rich Interactive Domain 1 (JARID1) histone demethylases.
Catalog No. Unit Price Qty
M60192-2s 2mg solid $139.00
M60192-2 10 mM in DMSO (0.620 mL) $139.00

Details

Product Information
Molecular Weight: 336.43
Formula: C17H28N4O3
Purity: ≥98%
CAS#: n/a
Solubility: DMSO up to 100 mM
Chemical Name: ethyl 2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinate
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

KDM5-C70 is an ethyl ester derivative of KDM5-C49, which is a potent and selective inhibitor of Jumonji AT-Rich Interactive Domain 1 (JARID1) histone demethylases. The highly polar carboxylate group of KDM5-C49 restricts its cellular permeability; therefore KDM5-C70 was developed as a pro-drug, masking the polarity of the acid group of the KDM5-C49, for cellular assays and in vivo use. KDM5-C70 increases H3K4me3 levels in myeloma cells. Treatment of MCF7 and MDA-MB-231 breast cancer cells with KDM5-C70 significantly increased global levels of H3K4me3 while having little impact on H3K4me2/me1 or modifications regulated by other histone lysine demethylases.

How to Use:


In vitro: KDM5-C70 was used at 1-10 µM in vitro and cellular assays.
In vivo: possible use for in vivo study (IP dosing 15-50 mg/kg, bid)

Reference:

  • 1. Marc Labelle, et al. Inhibitors of Histone Demethylases. (2014). PCT WO 2014053491
  • 2. Johansson C, et al. Structural analysis of human KDM5B guides histone demethylase inhibitor development. (2016) Nat Chem Biol. 12(7):539-45. 
  • 3. Horton JR, et al. Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds. (2016) Cell Chem Biol. 23(7):769-81. 

KDM5-C70_spec.pdf      

Products are for research use only. Not for human use. 

Description

Details

Product Information
Molecular Weight: 336.43
Formula: C17H28N4O3
Purity: ≥98%
CAS#: n/a
Solubility: DMSO up to 100 mM
Chemical Name: ethyl 2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinate
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

KDM5-C70 is an ethyl ester derivative of KDM5-C49, which is a potent and selective inhibitor of Jumonji AT-Rich Interactive Domain 1 (JARID1) histone demethylases. The highly polar carboxylate group of KDM5-C49 restricts its cellular permeability; therefore KDM5-C70 was developed as a pro-drug, masking the polarity of the acid group of the KDM5-C49, for cellular assays and in vivo use. KDM5-C70 increases H3K4me3 levels in myeloma cells. Treatment of MCF7 and MDA-MB-231 breast cancer cells with KDM5-C70 significantly increased global levels of H3K4me3 while having little impact on H3K4me2/me1 or modifications regulated by other histone lysine demethylases.

How to Use:


In vitro: KDM5-C70 was used at 1-10 µM in vitro and cellular assays.
In vivo: possible use for in vivo study (IP dosing 15-50 mg/kg, bid)

Reference:

  • 1. Marc Labelle, et al. Inhibitors of Histone Demethylases. (2014). PCT WO 2014053491
  • 2. Johansson C, et al. Structural analysis of human KDM5B guides histone demethylase inhibitor development. (2016) Nat Chem Biol. 12(7):539-45. 
  • 3. Horton JR, et al. Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds. (2016) Cell Chem Biol. 23(7):769-81. 

KDM5-C70_spec.pdf      

Products are for research use only. Not for human use. 

Reviews

Write Your Review

How do you rate this product? *

Price:
Value:
Quality: